|
|
|
|
|
|
NEWS
|
|
|
|
|
|
|
|
|
|
BIOMAX EMPOWERS MEDICAL AND ECONOMIC SUCCESS AT CIRO+
|
|
Recent business analysis revealed that the CIRO+ Center of Expertise for Chronic Organ Failure realized an approximately 30% efficiency gain per patient. Since 2006, the number of patients treated at CIRO+ clinics doubled, patient outcomes improved by 50%, while costs went up by only 25%. Professor Dr. Emiel Wouters, Chairman of the CIRO+ Board of Directors, links the success to the center's ongoing alliance with Biomax: "Implementing our ambitious, multidisciplinary approach only became possible through the collaboration with Biomax. The Biomax BioXM system has been in routine use at CIRO+ clinics 24/7 for the past two years and has allowed us to scale up most efficiently." Read more here.
|
|
|
|
|
|
|
|
|
|
YOUR VISCOVERY JUST GOT BETTER — GET THE TRIAL VERSION TODAY
|
|
The Viscovery® SOMine Suite offers unique, patented technology for explorative analysis and predictive modeling of complex data using the combined power of self-organizing maps (SOMs) and multivariate statistics. The recently launched version 7 brings a new modular architecture and a number of improved analytic features. For better handling of Big Data give your research the Viscovery lift it deserves. Download a summary of Viscovery features, including the new release, here. Get a free trial version here.
|
|
|
|
|
|
|
|
|
|
|
APPLICATIONS
|
|
|
|
|
|
|
|
|
|
IMPLEMENTING SYSTEMS MEDICINE WITHIN HEALTHCARE
|
|
Scientists and practitioners from ten of Europe's leading health-related organizations published systems medicine approaches and guidelines for translation into healthcare which have been shown to work in respiratory medicine. The collaborative efforts of the Genome Medicine paper's thirteen authors stem from the Biomax/CASyM symposium, Translating Systems Medicine into Practice. The paper discusses proof-of-principle examples of systems medicine and proposes a high-level implementation strategy. Read more.
|
|
|
|
|
|
|
|
|
|
IMPACT OF COMORBIDITIES ON COPD REHABILITATION — BIOMAX, VISCOVERY PLAY KEY ROLE IN PATIENT STUDY
|
|
Scientists at CIRO+ and Biomax have published results describing the impact of objectively identified comorbidities on COPD rehabilitation outcomes. The Viscovery® data mining software was used to create clusters of disorders co-occurring with COPD and explore changes in patients’ exercise performance and health status after pulmonary rehabilitation. The Mesquita et al (2015) paper is one result of the ongoing cooperation between Biomax and CIRO+ to provide patients with customized treatments that improve therapy outcomes. Learn more about the collaboration at the Biomax Website.
|
|
|
|
|
|
|
|
|
|
CONNECTING AIR POLLUTION WITH ASTHMA — HOW BIOMAX INTEGRATION, HARMONIZATION AND MANAGEMENT HELP
|
|
Early exposure to air pollution associates with asthma, but not rhinoconjunctivitis throughout childhood and adolescence. A highly collaborative, multi-year, European Union-funded project, MeDALL (Mechanisms of the Development of Allergy), was able to publish corresponding results in November 2015 in The Lancet Respiratory Medicine. Biomax and experts from 22 other academic and industrial institutions took a holistic, systems medicine approach to generate novel knowledge surrounding allergies. The Biomax BioXM™ Knowledge Management Environment is used to structure and semantically integrate the diverse information provided by the consortium. Learn more at the Biomax Website.
|
|
|
|
|
|
|
|
|
|
|
EDUCATION
|
|
|
|
|
|
|
|
|
|
SPOTTING TRENDS IN HEALTHCARE
|
|
As a partner to many critical players driving the evolution of healthcare, Biomax is in a unique position to spot trends in the wider healthcare landscape. Two of our experts report back on some of the hot topics revealed at recent meetings of the European Respiratory Society (ERS), European Federation of Allergy and Airways Diseases Patients Associations (EFA) and the Dutch Lung Centers. Read more:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EVENTS — OPPORTUNITIES TO MEET AND DISCUSS YOUR NEEDS WITH BIOMAX
|
|
|
|
|
|
|
|
|
|
DESIGNING THE SMART HOSPITAL — CREATING THE HOSPITALS OF THE FUTURE
|
|
|
2016 PLANT AND ANIMAL GENOME CONFERENCE (PAG XXIV)
|
|
|
|
|
|
|
|
|
|
SEASON'S GREETINGS
|
|
|
|
|
|
|
|
|
We would like to thank our clients for making 2015 the most successful year in the history of Biomax. We experienced double-digit growth rates in all business areas and expansion of our client base in two dimensions: geographically and across disciplines. Our global reach expanded with the establishment of our headquarters in the United States to serve the Americas and Asia. The diversity of our client base expanded as our core technology, the BioXM™ Knowledge Management platform, was embraced in the life sciences, healthcare and beyond.
This made 2015 the most satisfying year in the history of Biomax, as well. Many of our clients recognized the profound potential of using systematic knowledge management (KM) to better understand complex systems and handle Big Data. Biomax saw this potential realized first hand, helping new customers establish sustainable KM in their organizations and guiding many of our long-term customers in expanding their KM efforts into new areas. We thank our clients for the confidence they have in us as a collaborative partner in realizing their most pressing objectives.
Satisfied clients are our best measure of success and we’re excited to see where knowledge management will take them (and us!) in 2016. This is our wish for you too.
How can Biomax help you make 2016 your most successful and satisfying year to date?
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Biomax Informatics AG
Robert-Koch Str. 2
D-82152 Planegg
Germany
|
+49 89 895574-0 (Germany)
+44 7832 965 326 (United Kingdom)
+1 608 636 2222 (Americas and Japan)
|
|
|
|
|
|
|
|
|
|
|
Biomax and BioXM are trademarks of Biomax Informatics AG in Germany and other countries.
Viscovery is a registered trademark of Viscovery Software GmbH.
Viscovery Software GmbH is a company member within the Biomax Group.
|
Biomax Informatics AG
Registered Office (Sitz der Gesellschaft): Planegg, Germany
Court of Registration (Registergericht): AG München, HRB 134442
CEO (Vorstandsvorsitzender): Dr. Klaus Heumann
Chairman of the Supervisory Board (Vorsitzender des Aufsichtsrats): Prof. Dr. Hans-Werner Mewes
|
|
|
|
Unsubscribe
|
|
